drugset / Trial / NCT00123643

Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients

NCT00123643

Phase 4 Completed 36 enrolled St. Paul Heart Clinic GlaxoSmithKline · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to compare the vascular effects of two commonly used diabetes medications, rosiglitazone and glyburide in type 2 diabetic patients.

Timeline

Start
2003-05
Primary completion
2005-12
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Glyburide Small molecule
Subject Rosiglitazone Small molecule